Welcome

NIH to Examine Use of Eliquis in Third Covid-19 Treatment Trial

March 8, 2021, 4:35 PM

The National Institutes of Health is enrolling for the last of three Phase 3 clinical trials to evaluate the use of Bristol Myers Squibb and Pfizer Inc.’s Eliquis to treat blood clots in Covid-19 patients .

  • Trials seeks to answer critical questions about the proper use of blood thinners or anticoagulants in treatment of Covid-19 patients, particularly those who suffer from life-threatening blood clots

To view the source of this information click here

To contact the reporter on this story:
Sebastian Tong in San Francisco at stong41@bloomberg.net

To contact the editor responsible for this story:
Angela Moon at hmoon43@bloomberg.net

© ...

To read the full article log in.

Learn more about a Bloomberg Law subscription.